(Q33739836)

29 July 2017

title

Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin (English)

1 reference

29 July 2017

main subject

Pseudomonas aeruginosa

0 references

author name string

Blaser J

1

1 reference

29 July 2017

Dudley MN

2

1 reference

29 July 2017

Gilbert D

3

1 reference

29 July 2017

Zinner SH

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

29

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

927-929

1 reference

Method of reliable determination of minimal lethal antibiotic concentrations

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Proposed quality control and interpretive criteria for disk diffusion susceptibility testing with enoxacin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Serum Dilution Test for Bactericidal Activity. I. Selection of a Physiologic Diluent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Cephradine concentrations in serum, pleural fluid, pleura, and lung of normal rabbits

21 June 2018

1 reference

12 December 2020

1 reference

12 December 2020

Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin

1 reference

12 December 2020

Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: A comparative double-blind study

1 reference

12 December 2020

Reversal of the Antibacterial Activity of Polymyxin by Divalent Cations

1 reference

12 December 2020

The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity

1 reference

12 December 2020

Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.29.5.927

1 reference

29 July 2017

1 reference

29 July 2017

1 reference